HighTower Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

HighTower Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.38M	Buy	+40,899	New	+$2.67M	﹤0.01%	1691
2018 Q4	–	Sell	-22,763	Closed	-$899K	–	2347
2018 Q3	$899K	Buy	22,763 +7,065	+45%	+$268K	0.01%	1177
2018 Q2	$586K	Buy	15,698 +1,375	+10%	+$49.9K	﹤0.01%	1375
2018 Q1	$488K	Buy	14,323 +5,575	+64%	+$195K	﹤0.01%	1423
2017 Q4	$285K	Buy	+8,748	New	+$274K	﹤0.01%	1733

Other funds holding SBIO

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Silver Oak Securities Jackson, Tennessee $1.36B AUM 21.31% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

HighTower Advisors's SBIO Position: Q3 2026 in Review

HighTower Advisors opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q3 2026: 40,899 shares worth $2.38M. The stake represents ﹤0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in SBIO as recently as Q3 2018.

HighTower Advisors first reported a position in SBIO in Q4 2017 and has held it in 5 quarters since. 49 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

HighTower Advisors held 40,899 shares of ALPS Medical Breakthroughs ETF worth $2.38M as of Q3 2026.
ALPS Medical Breakthroughs ETF was a new HighTower Advisors position in Q3 2026.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #1691 holding.
HighTower Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2017 and has held it in 5 quarters since.
49 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.